期刊文献+

肿瘤免疫逃逸和免疫抑制的机制和免疫治疗策略的研究进展 被引量:5

Progress in anti-tumor immune mechanisms and treatment strategy
原文传递
导出
摘要 免疫治疗是抗肿瘤治疗的一项重要的辅助治疗手段.有效的激活自身抗肿瘤免疫系统对早期肿瘤的治疗有重要意义.与传统的应用靶点特异性抗体不同,研究者更倾向于对肿瘤组织内部的免疫应答过程进行深入研究,从而期望制定出更有效的肿瘤免疫治疗方案.肿瘤细胞处于不利于诱导抗肿瘤免疫应答的微环境中是肿瘤免疫治疗面临的主要困难之一. Immunotherapy is an important auxiliary anti-tumor treatment.It has important significance for treatment of early stage tumors by activating antitumor immune system effectively.Instead of novel checkpoint-blocking antibodies,recent insight into innate immune system may further improve cancer immunotherapy strategy and help to overcome the limitations of conventional strategies.A major hurdle for tumor immunotherapy is that the majority of tumor cells are located in an immunosuppressive tumor environment.This paper reviews the novel immunotherapeutic approaches for targeting established cancers.
出处 《国际免疫学杂志》 CAS 2014年第4期272-275,共4页 International Journal of Immunology
基金 国家自然科学基金(81172238)
关键词 肿瘤 免疫治疗 微环境 Tumor Immunotherapy Microenvironment
  • 相关文献

参考文献31

  • 1Coley WB.II.Contribution to the Knowledge of Sarcoma[J].Ann Surg,1891,14(3):199-220.
  • 2Dunn GP,Bruce AT,Ikeda H,et al.Cancer immunoediting:from immunosurveillance to tumor escape[J].Nat Immunol,2002,3(11):991-998.
  • 3Matsushita H,Vesely MD,Koboldt DC,et al.Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting[J].Nature,2012,482(7385):400-404.
  • 4DuPage M,Mazumdar C,Schmidt LM,et al.Expression of tumour-specifie antigens underlies cancer immunoediting[J].Nature,2012,482(7385):405-409.
  • 5Landsberg J,Kohlmeyer J,Renn M,et al.Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation[J].Nature,2012,490(7420):412-416.
  • 6Landsberg J,Gaffal E,Cron M,et al.Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillance[J].Pigment Cell Melanoma Res,2010,23(5):649-660.
  • 7Kohlmeyer J,Cron M,Landsberg J,et al.Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy[J].Cancer Res,2009,69 (15):6265-6274.
  • 8Nowell PC.The clonal evolution of tumor cell populations[J].Science,1976,194 (4260):23-28.
  • 9Gerlinger M,Rowan AJ,Horswell S,et al.Intratumor heterogeneity and branched evolution revealed by multiregion sequencing[J].N Engl J Med,2012,366(10):883-892.
  • 10Gorre ME,Mohammed M,Ellwood K,et al.Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification[J].Science,2001,293(5531):876-880.

同被引文献79

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部